✦ LIBER ✦

A randomized, controlled trial of interferon alfa-2b alone and with simultaneous prednisone for the treatment of chronic hepatitis B

✍ Scribed by Jean-Pierre Zarski; Xavier Causse; Marielle Cohard; Jean Cougnard; Christian Trepo

Book ID: 118566142
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 475 KB
Volume: 20
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(05)80143-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of chronic hepatitis B in chil

Treatment of chronic hepatitis B in children with prednisone followed by alfa-interferon: a controlled randomized study

✍ Riccardo Utili; Evangelista Sagnelli; Giovanni B. Gaeta; Bruno Galanti; Salvator 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 400 KB

A randomized, double-blind trial compari

A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C

✍ Karen L. Lindsay; Christian Trepo; Tobias Heintges; Mitchell L. Shiffman; Stuart 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

Treatment of chronic hepatitis B with in

Treatment of chronic hepatitis B with interferon (IFN)alfa and prednison. An alternative for nonresponders

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Interferon alfa treatment of chronic hep

Interferon alfa treatment of chronic hepatitis B: Randomized trial in a predominantly homosexual male population

✍ David K.H. Wong; Colina Yim; C.David Naylor; Erluo Chen; Morris Sherman; Stephen 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 675 KB

Treatment of hepatitis C virus–related c

Treatment of hepatitis C virus–related cirrhosis: A randomized, controlled trial of interferon alfa-2b versus no treatment

✍ Dominique-Charles Valla; Michele Chevallier; Patrick Marcellin; Jean-Louis Payen 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

To examine the effects of interferon (IFN) therapy on clinical, biochemical, and histological features in patients with compensated hepatitis C virus (HCV)-related cirrhosis, we have conducted a randomized, controlled trial of IFN therapy versus observation. Eight centers included a total of 99 pati

A randomized controlled trial of thymosi

A randomized controlled trial of thymosin-α1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody—and hepatitis B virus DNA—positive chronic hepatitis B

✍ P Andreone; C Cursaro; A Gramenzi; C Zavaglia; I Rezakovic; E Altomare; R Severi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 1 views

ment for anti-HBe-positive chronic hepatitis. The benefit It has recently been shown that thymosin-a 1 (T-a 1 ), a of this agent in producing long-term inhibition of HBV synthetic polypeptide of thymic origin, is able to proreplication must be confirmed by future trials. (HEPAmote disease remission